Acrospire Investment Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-4,435
Closed -$49K 124
2017
Q2
$49K Buy
+4,435
New +$49K 0.05% 871
2016
Q4
Sell
-2,955
Closed -$37K 2194
2016
Q3
$37K Buy
+2,955
New +$37K 0.02% 1230
2016
Q2
Sell
-3,955
Closed -$44K 2014
2016
Q1
$44K Buy
+3,955
New +$44K 0.03% 1054